Department of Pharmaceutical Analysis :
The department of Pharmaceutical Analysis was established in 2011. The objective was to train the pharmacy graduates in quality assurance to cater the ever-increasing need of pharmaceutical industry and academia. The department is well-equipped with sophisticated analytical instruments and competent manpower. The research focus of the department is analytical and bioanalytical method development and validation, stability studies, impurity profiling and pharmacokinetic studies.
Significance :
- State of the art facility.
- Diversified capabilities.
- Team of academicians with rich expertise and exposure.
- Expertized and focused analytical services.
Scope :
The department of Pharmaceutical Analysis was established in 2011. The objective was to train the pharmacy graduates in quality assurance to cater the ever-increasing need of pharmaceutical industry and academia. The department is well-equipped with sophisticated analytical instruments and competent manpower. The research focus of the department is analytical and bioanalytical method development and validation, stability studies, impurity profiling and pharmacokinetic studies.
INDUSTRIAL MoU:The department has signed MoU with SAI MEERA PHARMACEUTICALS (PVT) LTD,Chennai.
Instrumentation :
- UV -pectrophotometer
- High Performance Liquid Chromatography
- Flame Photometer
- Conductivity meter
- Fluorimeter
- Digital BalanceR 200 D
Departmental activities :
- 1. Stability indicating assay methods of pharmaceuticals and their combined dosages by HPLC .
- 2. Bioanalytical method development and validation of drugs and its metabolites by HPLC for its pharmacokinetic evaluation.
- 3. Dissolution development of drugs in its combined dosage forms.
- 4. Drug-drug interaction studies.
- 5. Stability studies of active pharmaceutical ingredients and dosage forms as per ICH guidelines.
- 6. Analytical method development of drugs present in combined dosage forms.
- 7. Forced degradation studies (Stress conditions) and accelerated stability conditions of API and combined dosage forms.